Mark Stenhouse's Net Worth
$3.62 Million
Who is Mark Stenhouse?
Mark Stenhouse has an estimated net worth of $3.62 Million. This is based on reported shares across multiple companies, which include Prometheus Biosciences, Inc., EXACT SCIENCES CORP, and Phathom Pharmaceuticals, Inc..
SEC CIK
Mark Stenhouse's CIK is 0001734751
Past Insider Trading and Trends
2020 was Mark Stenhouse's most active year for acquiring shares with 5 total transactions. Mark Stenhouse's most active month to acquire stocks was the month of April. 2023 was Mark Stenhouse's most active year for disposing of shares, totalling 7 transactions. Mark Stenhouse's most active month to dispose stocks was the month of May. 2021 saw Mark Stenhouse paying a total of $266,000.00 for 96,871 shares, this is the most they've acquired in one year. In 2019 Mark Stenhouse cashed out on 36,192 shares for a total of $1,035,696.49, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Prometheus Biosciences, Inc. No price found
Chief Operating OfficerMark Stenhouse used to own units in Common Stock but no longer holds any shares there. In the year 2021 Mark Stenhouse acquired a total of 23,811 shares in Prometheus Biosciences, Inc. at a cost of $266,000.00, Mark also disposed a total of 26,754 shares of Prometheus Biosciences, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -26.75K |
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
| 26.71K |
Jun 1
| |||
Form 4
| +58.99% | 9.81K |
—
|
—
| 26.44K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
∞
| 14K |
$19.00 | $266,000.00 | 14K |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EXACT SCIENCES CORP (EXAS) Snapshot price: $59.11
President, CologuardMark Stenhouse owns 29,571 units of Common Stock which is worth $1,747,941.81. In the year 2018 Mark Stenhouse filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +79.01% | 13.05K |
$56.69 | -$677,332.12 | 29.57K |
Scheduled
|
Apr 2 - Apr 3
| ||
Form 4
| +15.45% | 2.21K |
$80.27 | -$84,363.77 | 16.52K |
Scheduled
|
Feb 26 - Feb 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +2,761.60% | 13.81K |
$92.54 | -$1,035,696.49 | 14.31K |
Scheduled
|
Apr 2 - Apr 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $17.55
InvestorMark Stenhouse owns 19,500 units of Common Stock which is worth $342,225.00. From 2020 to 2024 Mark Stenhouse acquired a total of 19,500 shares in Phathom Pharmaceuticals, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +116.67% | 10.5K |
—
|
—
| 19.5K |
May 23
| |||
Form 4
|
∞
| 9K |
—
|
—
| 9K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||